305 related articles for article (PubMed ID: 36831673)
1. Challenges in Diagnosis and Treatment of Pancreatic Exocrine Insufficiency among Patients with Pancreatic Ductal Adenocarcinoma.
Lan X; Robin G; Kasnik J; Wong G; Abdel-Rahman O
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831673
[TBL] [Abstract][Full Text] [Related]
2. The impact of nutritional status on pancreatic cancer therapy.
Capurso G; Pecorelli N; Burini A; Orsi G; Palumbo D; Macchini M; Mele R; de Cobelli F; Falconi M; Arcidiacono PG; Reni M
Expert Rev Anticancer Ther; 2022 Feb; 22(2):155-167. PubMed ID: 34989653
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic Exocrine Insufficiency as a Complication of Gastrointestinal Surgery and the Impact of Pancreatic Enzyme Replacement Therapy.
Chaudhary A; Domínguez-Muñoz JE; Layer P; Lerch MM
Dig Dis; 2020; 38(1):53-68. PubMed ID: 31422398
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and management of pancreatic exocrine insufficiency.
Nikfarjam M; Wilson JS; Smith RC;
Med J Aust; 2017 Aug; 207(4):161-165. PubMed ID: 28814218
[TBL] [Abstract][Full Text] [Related]
5. Contribution of pancreatic enzyme replacement therapy to survival and quality of life in patients with pancreatic exocrine insufficiency.
Layer P; Kashirskaya N; Gubergrits N
World J Gastroenterol; 2019 May; 25(20):2430-2441. PubMed ID: 31171887
[TBL] [Abstract][Full Text] [Related]
6. Fat malabsorption in pancreatic cancer: Pathophysiology and management.
Murray G; Ramsey ML; Hart PA; Roberts KM
Nutr Clin Pract; 2024 Apr; 39 Suppl 1():S46-S56. PubMed ID: 38429964
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and treatment of pancreatic exocrine insufficiency.
Dominguez-Muñoz JE
Curr Opin Gastroenterol; 2018 Sep; 34(5):349-354. PubMed ID: 29889111
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic Cancer Malnutrition and Pancreatic Exocrine Insufficiency in the Course of Chemotherapy in Unresectable Pancreatic Cancer.
Kiriukova M; de la Iglesia Garcia D; Panic N; Bozhychko M; Avci B; Maisonneuve P; de-Madaria E; Capurso G; Sandru V
Front Med (Lausanne); 2020; 7():495. PubMed ID: 33015088
[TBL] [Abstract][Full Text] [Related]
9. Impact of the treatment of pancreatic exocrine insufficiency on survival of patients with unresectable pancreatic cancer: a retrospective analysis.
Domínguez-Muñoz JE; Nieto-Garcia L; López-Díaz J; Lariño-Noia J; Abdulkader I; Iglesias-Garcia J
BMC Cancer; 2018 May; 18(1):534. PubMed ID: 29728096
[TBL] [Abstract][Full Text] [Related]
10. Fat-Soluble Vitamin Deficiencies and Disruption of the Immune System in Pancreatic Cancer: A Vicious Cycle.
Aziz MH; van der Meulen J; Mustafa DAM; van Eijck CHJ
Pancreas; 2022 Sep; 51(8):923-929. PubMed ID: 36607936
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic Enzyme Replacement Therapy in Pancreatic Cancer.
Pezzilli R; Caccialanza R; Capurso G; Brunetti O; Milella M; Falconi M
Cancers (Basel); 2020 Jan; 12(2):. PubMed ID: 31979186
[TBL] [Abstract][Full Text] [Related]
12. Management of pancreatic exocrine insufficiency.
Dominguez-Muñoz JE
Curr Opin Gastroenterol; 2019 Sep; 35(5):455-459. PubMed ID: 31219829
[TBL] [Abstract][Full Text] [Related]
13. Inhibition Effect of Pancreatic Exocrine Insufficiency on Immune Checkpoint Inhibitor Treatment in Pancreatic Cancer: A Retrospective Study.
Luo Q; Dong Y; Liu P; He C; Chen L; Zhang K; Pan C; Gao Y; Qin T
Immunotargets Ther; 2024; 13():45-54. PubMed ID: 38317658
[TBL] [Abstract][Full Text] [Related]
14. Expert opinion on management of pancreatic exocrine insufficiency in pancreatic cancer.
Roeyen G; Berrevoet F; Borbath I; Geboes K; Peeters M; Topal B; Van Cutsem E; Van Laethem JL
ESMO Open; 2022 Feb; 7(1):100386. PubMed ID: 35124465
[TBL] [Abstract][Full Text] [Related]
15. Prescription patterns of pancreatic enzyme replacement therapy for patients with pancreatic cancer in the United States.
Jain T; Sharma P; Giri B; Iyer S; Sethi V; Bava EP; Vaish U; Sahay P; Datta J; Reddy S; Bart Rose J; Khan A; Merchant N; Chari ST; Dudeja V
HPB (Oxford); 2022 Oct; 24(10):1729-1737. PubMed ID: 35717430
[TBL] [Abstract][Full Text] [Related]
16. Nutritional and Metabolic Derangements in Pancreatic Cancer and Pancreatic Resection.
Gilliland TM; Villafane-Ferriol N; Shah KP; Shah RM; Tran Cao HS; Massarweh NN; Silberfein EJ; Choi EA; Hsu C; McElhany AL; Barakat O; Fisher W; Van Buren G
Nutrients; 2017 Mar; 9(3):. PubMed ID: 28272344
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and management of pancreatic exocrine insufficiency (PEI) in primary care: consensus guidance of a Canadian expert panel.
Durie P; Baillargeon JD; Bouchard S; Donnellan F; Zepeda-Gomez S; Teshima C
Curr Med Res Opin; 2018 Jan; 34(1):25-33. PubMed ID: 28985688
[TBL] [Abstract][Full Text] [Related]
18. Clinical, anthropometric and laboratory nutritional markers of pancreatic exocrine insufficiency: Prevalence and diagnostic use.
Lindkvist B; Phillips ME; Domínguez-Muñoz JE
Pancreatology; 2015; 15(6):589-97. PubMed ID: 26243045
[TBL] [Abstract][Full Text] [Related]
19. Understanding pancreatic exocrine insufficiency and replacement therapy in pancreatic cancer.
Powell-Brett S; de Liguori Carino N; Roberts K
Eur J Surg Oncol; 2021 Mar; 47(3 Pt A):539-544. PubMed ID: 32178962
[TBL] [Abstract][Full Text] [Related]
20. Maldigestion from pancreatic exocrine insufficiency.
Pongprasobchai S
J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():99-102. PubMed ID: 24251713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
